The incidence of herpes zoster was determined in patients with systemic lupus erythematosus (SLE) and the cellular and humoral immunity to varicella zoster virus (VZV) investigated in 45 of these 92 patients.
Herpes zoster, a form of recurrent infection of varicella zoster virus (VZV), may often develop in elderly subjects' 2 and immunocompromised hosts.' The latter include patients with malignancies, especially lymphoproliferative diseases, and certain types of autoimmune diseases, such as systemic lupus erythematosus (SLE). 15 The suppression of cellular immunity has been implicated in the pathogenesis of reactivation of VZV, herpes zoster, because recurrent VZV infections occur in patients with antibodies against VZV. 4 7 Immunological studies on patients with SLE showed a defective delayed hypersensitivity reaction'°and a hyperactive humoral immunlity.1 12 Corticosteroids or immunosuppressive treatments for SLE, or both, may lead to a further reduction in the host resistance to infections. 13 14 The association of herpes zoster with SLE has not been fully studied, however, and there are few reports on it.""'9 During our 10 year observation of patients with SLE we have noted that herpes zoster occurs in patients with SLE much more commonly than generally expected.
We report here the incidence of herpes zoster in these patients with SLE, and the effects of immunological state on the pathogenesis of herpes zoster are discussed.
Patients and methods

PATIENTS WITH CONTROLS
Ninety two patients (89 women, three men) who fulfilled the criteria of the American Rheumatism Association for SLE20 were enrolled in this study. They had a mean age of 36-8 (range 19-68) years. The history of herpes zoster was obtained at interview with the patients and was confirmed by doctors' records.
Cellular and humoral immunity to VZV was evaluated in 45 of these 92 patients (44 women and one man with a mean age of 37-2 (range 22-68) years) and in 15 healthy subjects with no history of zoster (11 women and four men with a mean age of 35-0 (23-52) years). Patients with a history of herpes zoster within the last six months were excluded from the immunological study. At the time of the immunological study 36 (table 3) . As shown, the positivity of skin reactions correlated with the T4/T8 ratio. In patients with a T4/T8 ratio of 1-0 or more the number of those with positive skin test was higher than that in those with a T4/T8 ratio of less than 0-5 (p<0 05).
Discussion
The annual incidence of herpes zoster is estimated to be less than 0-5% of the general population,26 27 and most are elderly' 28 29 or immunosuppressed subjects.' 6 35 According to our study, 10 mg/day of prednisolone seems to be the borderline dose. Although immunosuppressive drugs such as cyclophosphamide and azathioprine given to nine patients in a dose of 50 mg/day seemed to have little effect on the skin test and antibody response, the evaluation was difficult because of small numbers. Our results also indicate that the skin reactions correlated with the OKT4/8 ratio in patients with SLE. In untreated patients with SLE decreased CD4 and normal or increased CD8 cells are often noted.36 37 Corticosteroid treatment preferentially decreases CD4 cells and thus decreases the T4/T8 ratio.37 In our study the number of patients with SLE with a T4/T8 ratio over 10 accounted for only 11 of the 43 tested (26%). This low ratio may explain the poor skin reactions to VZV and the high incidence of zoster.
Sensitivity of the antibody detected by complement fixation is poor compared with that detected by the neutralising test, and in normal subjects the former disappears within one year after a primary infection whereas the latter is detectable for a lifelong period. 
